News
AstraZeneca initiates phase III clinical programme evaluating NKTR-118
AstraZeneca announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the treatment...
News
Lilly Announces New Vice President of Oncology Research
Eli Lilly and Company announced that Greg Plowman, M.D., Ph.D., will lead Lilly's oncology research efforts as the vice president, oncology research and senior vice...
News
Amgen Donates $1 Million to Help Japanese Disaster Victims
Amgen announced that the company will donate $1 million to Japanese disaster relief efforts. Amgen and the Amgen Foundation will distribute the funds to both...
News
Takeda’s Donation to Aid Earthquake Relief Efforts in Japan
Takeda Pharmaceutical Company Limited announced 300 million Japanese yen donation to aid emergency relief for the earthquake on March 11, through The Japanese Red Cross...
News
Bristol-Myers Squibb Foundation Announces Funding of Nearly $1 Million...
The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and care of hepatitis B (HBV) and hepatitis C (HCV) in...
News
Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
Pfizer Inc. announced that it has combined operations with King Pharmaceuticals, Inc. On February 28, 2011, Pfizer completed its acquisition of King through the merger...
News
Pharma Idol Winner Announced
Since launching in November, eyeforpharma's Pharma Idol competition has caused quite a stir in the industry and not just due to the launch video featuring...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.